After the challenge (hrs) | |||||||||
Patients n = 23 | Before the challenge | 1 | 6 | 12 | 24 | 36 | 48 | 56 | 72 |
Leukocytes□ | |||||||||
DYAR | 8.9 ± 0.5 | 10.1 ± 0.8 | 10.5 ± 0.4 | 11.9 ± 0.9+ | 12.7 ± 0.5* | 13.5 ± 0.6* | 12.9 ± 0.7* | 11.6 ± 0.3+ | 10.0 ± 0.5 |
PBS | 8.3 ± 0.4 | 7.9 ± 0.7 | 7.8 ± 1.0 | 8.2 ± 0.9 | 7.4 ± 0.5 | 8.4 ± 1.0 | 8.0 ± 0.6 | 7.9 ± 0.5 | 8.1 ± 0.4 |
Eosinophils□□ | |||||||||
DYAR | 293 ± 27 | 332 ± 35 | 318 ± 24 | 343 ± 30 | 281 ± 29 | 272 ± 27 | 301 ± 30 | 247 ± 25 | 288 ± 34 |
PBS | 285 ± 21 | 309 ± 45 | 293 ± 26 | 268 ± 22 | 311 ± 47 | 256 ± 22 | 295 ± 29 | 287 ± 34 | 276 ± 23 |
Neutrophils□□□ | |||||||||
DYAR | 6.4 ± 0.3 | 6.7 ± 0.9 | 6.6 ± 0.5 | 10.1 ± 0.8* | 10.5 ± 0.7* | 9.4 ± 1.1* | 8.7 ± 0.4* | 7.1 ± 0.3 | 6.2 ± 0.6 |
PBS | 5.9 ± 1.1 | 6.0 ± 0.8 | 6.9 ± 0.4 | 6.1 ± 0.5 | 6.5 ± 0.9 | 7.1 ± 0.4 | 6.8 ± 0.7 | 6.2 ± 0.5 | 6.4 ± 0.3 |
Thrombocytes○ | |||||||||
DYAR | 343 ± 41 | 320 ± 25 | 329 ± 23 | 347 ± 40 | 368 ± 34 | 415 ± 53 | 386 ± 31 | 319 ± 27 | 333 ± 29 |
PBS | 298 ± 17 | 336 ± 37 | 323 ± 25 | 299 ± 16 | 354 ± 27 | 318 ± 21 | 349 ± 38 | 301 ± 20 | 285 ± 26 |
Differential count○○ | |||||||||
Eosinophils | |||||||||
DYAR | 0.41 | 0.52 | 0.40 | 0.58 | 0.39 | 0.53 | 0.36 | 0.38 | 0.29 |
PBS | 0.34 | 0.37 | 0.39 | 0.34 | 0.26 | 0.43 | 0.25 | 0.26 | 0.19 |
Neutrophils | |||||||||
DYAR | 6.4 | 6.8 | 6.5 | 8.5* | 9.4* | 9.8* | 9.1* | 8.9* | 7.0 |
PBS | 6.0 | 6.3 | 6.7 | 5.5 | 6.6 | 6.9 | 5.8 | 7.1 | 5.9 |
Basophils | |||||||||
DYAR | 0.06 | 0.09 | 0.10 | 0.05 | 0.10 | 0.05 | 0.09 | 0.06 | 0.15 |
PBS | 0.07 | 0.03 | 0.05 | 0.10 | 0.08 | 0.09 | 0.04 | 0.09 | 0.05 |
Monocytes | |||||||||
DYAR | 0.55 | 0.6 | 1. 0 | 1.9* | 1.8* | 1.7* | 1.1+ | 0.5 | 0.6 |
PBS | 0.35 | 0.2 | 0.7 | 0.6 | 0.5 | 0.35 | 0.45 | 0.25 | 0.5 |
Lymphocytes | |||||||||
DYAR | 2.8 | 3.1 | 3.8+ | 3.5 | 4.7* | 4.8* | 3.9+ | 2.5 | 2.4 |
PBS | 2.4 | 2.2 | 3.4 | 3.7 | 2.9 | 3.0 | 2.6 | 2.3 | 2.5 |
Th1/Th2 ratio (%)∆ | |||||||||
DYAR | 8.0 ± 1.5 | 8.6 ± 2.1 | 9.9 ± 3.0+ | 14.7 ± 4.0* | 16.2 ± 3.5* | 17.1 ± 3.0* | 16.4 ± 3.4* | 15.6 ± 4.5* | 9.1 ± 2.2 |
PBS | 7.3 ± 3.1 | 8.2 ± 3.0 | 9.4 ± 2.1 | 7.5 ± 3.4 | 8.8 ± 3.7 | 9.0 ± 4.1 | 9.3 ± 3.1 | 8.9 ± 4.2 | 7.6 ± 2.6 |
IFN-γ (pg/mL) | |||||||||
DYAR | 2.4 ± 0.5 | 2.7 ± 1.0 | 4.9 ± 0.4+ | 9.2 ± 1.7* | 9.0 ± 3.1* | 8.8 ± 3.2* | 7.1 ± 1.3* | 3.1 ± 1.0 | 2.9 ± 0.3 |
PBS | 2.1 ± 0.2 | 1.9 ± 0.8 | 2.2 ± 0.6 | 1.9 ± 0.8 | 2.4 ± 0.5 | 2.2 ± 1.0 | 2.5 ± 1.0 | 2.4 ± 0.5 | 2.3 ± 0.2 |
IL-4 (pg/mL) | |||||||||
DYAR | 3.0 ± 0.1 | 3.2 ± 0.1 | 3.5 ± 0.4 | 3.7 ± 0.6 | 3.2 ± 0.4 | 3.4 ± 0.3 | 3.5 ± 0.5 | 3.3 ± 0.5 | 3.5 ± 0.4 |
PBS | 3.1 ± 0.2 | 3.0 ± 0.2 | 3.3 ± 0.1 | 3.4 ± 0.5 | 3.5 ± 0.2 | 3.0 ± 0.2 | 3.4 ± 0.7 | 3.5 ± 0.6 | 3.2 ± 0.1 |